First patient treated in European cardioprotection phase III trial with NeuroVive’s CicloMulsion
Tuesday, April 19, 2011 - 15:50
in Health & Medicine
Lund Sweden -- April 19, 2011 -- NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of...